RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-eb3452c6cba2f813GRADE VERY_LOW
saffron — inflammation
direction BENEFIT · dose 100 mg; 200 mg; 30 mg; 400 mg · duration 12 weeks; 14 weeks; 21 days; 60 days; 7 days; 8 weeks
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
18bound studies
Bound studies (4 shown of 18)
STU-1f6a5e8535c7d1f2META_ANALYSIS · HUMAN · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-2ebec11c4432b9dfRCT · HUMAN · 2023 · 12 weeks · RoB SOME_CONCERNS
3 endpoints
STU-39075b3335e4243aRCT · HUMAN · 2026 · 12 weeks · RoB SOME_CONCERNS
3 endpoints
STU-576a88f5cfe48628ANIMAL · ANIMAL · 2026 · 14 weeks · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
inflammation p = .15 · validated
inflammation smd: -0.38 · validated
effect p < 0.05 | p < 0.05 · failed extraction
Opposition screen
SCREEN · 45 candidates considered · 0 bound as opposing
SYNTHESIS SYN-39c2b4f6d7f59f — outcome PARTIAL_SYNTHESIS · BENEFIT ×18 · not_assessed_quantitatively · 18 members
PROVENANCE → epmc:39657222, epmc:37801956, epmc:41439298 · PKG d3d54fd1fa19a95b…
CLAIM · CLM-3882fad77e747e4bGRADE VERY_LOW
saffron — antioxidant
direction BENEFIT · dose 100 mg; 15 mg; 20 mg · duration 12 months; 12 weeks; 14 weeks; 21 days; 35 days; 7 days
Grade basis — weakest-link ceilings
HIGHdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
LOWmethodology
MODERATEconsistency
MODERATEnumeric
14bound studies
Bound studies (4 shown of 14)
STU-01811c120a686465META_ANALYSIS · HUMAN · 2023 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-1f6a5e8535c7d1f2META_ANALYSIS · HUMAN · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-39075b3335e4243aRCT · HUMAN · 2026 · 12 weeks · RoB SOME_CONCERNS
3 endpoints
STU-576a88f5cfe48628ANIMAL · ANIMAL · 2026 · 14 weeks · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
effect smd: -0.322 | smd: -0.654 | smd: 0.302 | smd: 0.447 · failed extraction
n 466 · validated
inflammation p = .15 · validated
Opposition screen
SCREEN · 38 candidates considered · 0 bound as opposing
SYNTHESIS SYN-4dc4815c702ef6 — outcome QUALITATIVE_ONLY · BENEFIT ×14 · not_assessed_quantitatively · 14 members
PROVENANCE → epmc:36817799, epmc:39657222, epmc:41439298 · PKG d3d54fd1fa19a95b…
Bounded preview — representative records only. The full release ships 37 claims and 284 observations.